Outlook Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Outlook Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Outlook Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Outlook Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $16 | 15 | 1.07 |
| 2025-03-31 | $10k | 8.4k | 1.22 |
| 2024-12-31 | $14k | 7.5k | 1.89 |
| 2024-09-30 | $38k | 7.1k | 5.34 |
| 2024-06-30 | $26k | 3.6k | 7.38 |
| 2024-03-31 | $44k | 3.7k | 11.94 |